CYP27A1 and epilepsy: Furthermore, three patients carrying homozygous compound heterozygous CYP27A1 mutations causing CTX exhibited clinical symptoms such as ataxia, cataract, muscle atrophy, peripheral neuropathy, epilepsy, and pescavu.